Latest Keystone Heart Ltd. Stories

2014-05-15 12:33:31

CAESAREA, Israel, May 15, 2014 /PRNewswire/ -- Resources will be channeled towards randomized clinical studies and further commercialization. Keystone Heart will exhibit and present at EuroPCR next week in Paris. Keystone Heart, a medical device company and the developer of CE marked TriGuard(TM) Cerebral Protection Device [http://www.keystoneheart.com/products ], has successfully raised $14M in a series B round of financing led by OrbiMed. OrbiMed is a leading...

Word of the Day
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.